These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 13519397)

  • 21. [Treatment of ST-elevation acute coronary syndrome with the aim of reperfusion].
    ;
    Orv Hetil; 2005 Oct; 146(44):2271-2. PubMed ID: 16416564
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of antiplatelet factor 4/heparin antibody induction in patients undergoing percutaneous coronary revascularization.
    Gluckman TJ; Segal JB; Fredde NL; Saland KE; Jani JT; Walenga JM; Prechel MM; Citro KM; Zidar DA; Fox E; Schulman SP; Kickler TS; Rade JJ
    Am J Cardiol; 2005 Mar; 95(6):744-7. PubMed ID: 15757601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic urticaria responding to subcutaneous heparin sodium.
    Chua SL; Gibbs S
    Br J Dermatol; 2005 Jul; 153(1):216-7. PubMed ID: 16029359
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of evidence-based management for acute coronary syndrome.
    Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
    N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can enoxaparin safely replace unfractionated heparin during coronary intervention in acute coronary syndromes?
    Wolak A; Ayzenberg Y; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2004 Aug; 96(2):151-5. PubMed ID: 15262028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
    Califf RM; Petersen JL; Hasselblad V; Mahaffey KW; Ferguson JJ
    Am Heart J; 2005 Apr; 149(4 Suppl):S91-9. PubMed ID: 16124953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enoxaparin in non-ST segment elevation acute coronary syndromes: duration of therapy is essential to benefit.
    Steg PG; Juliard JM
    Eur Heart J; 2004 Oct; 25(19):1667-9. PubMed ID: 15451141
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversal of protein-losing enteropathy with heparin therapy in an adult patient with congenital heart disease.
    Tsuzuki T; Okada H; Takenaka R; Kawahara Y; Kato J; Okazaki H; Kawamoto H; Shiratori Y
    Digestion; 2006; 74(3-4):206-7. PubMed ID: 17341854
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of heparin in the antithrombotic treatment of valvulopathies.
    Hanania G
    J Heart Valve Dis; 2004 May; 13(3):339-43. PubMed ID: 15222278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of cold abscesses by in situ and intravenous injections of heparin].
    ALBERT-WEIL J
    Prensa Med Argent; 1954 Nov; 41(45):3221-7. PubMed ID: 13236996
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of heparin in the treatment of coronary diseases; heparin in coronary diseases except infarct].
    CAMERON-CURRY V
    Minerva Med; 1957 Jan; 48(6):183-7. PubMed ID: 13418464
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experience with discontinuous heparin in coronary insufficiency].
    SAN-CRISTOBAL D; SEPULVEDA G
    Rev Med Chil; 1953 Nov; 81(11):662-5. PubMed ID: 13156131
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-molecular-weight heparin vs. unfractionated heparin in percutaneous coronary intervention: a combined analysis.
    Borentain M; Montalescot G; Bouzamondo A; Choussat R; Hulot JS; Lechat P
    Catheter Cardiovasc Interv; 2005 Jun; 65(2):212-21. PubMed ID: 15900551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subcutaneous heparin treatment in cardiosclerosis].
    VON AHN B
    Sven Lakartidn; 1957 Dec; 54(52):3945-55. PubMed ID: 13519397
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.